Related Experiment Video
Updated: Jun 28, 2025

Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy
Published on: September 16, 2019
Hirschsprung's disease: m6A methylase VIRMA suppresses cell migration and proliferation by regulating GSK3β
Yang Yang1, Mengzhen Zhang1, Nan Li1
1Department of Pediatric Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, China.
Background:
N6-methyladenosine (m6A) is the most abundant mRNA modification in mammals, participating in various biological processes. VIRMA is a key methyltransferase involved in m6A modification. However, the role of VIRMA in Hirschsprung's disease (HSCR) remains unclear. This study aims to investigate the function of VIRMA in HSCR and identify its corresponding regulatory mechanisms.
Methods:
The expression of VIRMA and GSK3β in colon tissues of HSCR was examined using RT-qPCR, Western blot, and Immunohistochemistry. Immunofluorescence detected localization of VIRMA and GSK3β. Cell proliferation was measured by CCK8 and EdU assays, and cell migration was evaluated via cell migration and wound healing assays. The stability of GSK3β mRNA was assessed using the actinomycin D assay and the overall level of m6A in cells was assessed by colorimetric assay.
Results:
VIRMA was significantly downregulated in narrow-segment colon tissue. Silencing of VIRMA inhibited cell proliferation and migration. VIRMA can inhibit the degradation of GSK3β mRNA and increase the expression of GSK3β. GSK3β was significantly upregulated in narrow-segment colon tissues. Accordingly, our findings showed that GSK3β mediated the VIRMA-driven cell migration and proliferation.
Conclusion:
VIRMA can inhibit cell migration and proliferation by upregulating the expression of GSK3β, contributing to the onset of HSCR.
Impact:
The expressions of VIRMA were significantly reduced in HSCR, while GSK3β expression was increased in HSCR, and can be used as a molecular marker. VIRMA overexpression promoted the proliferation and migration of SH-SY5Y and HEK-293T cells. VIRMA can inhibit the degradation of GSK3β mRNA and increase the expression of GSK3β.
Insights
VIRMA, a key enzyme in RNA modification, is reduced in Hirschsprung's disease (HSCR). Its downregulation impairs cell growth and movement by increasing GSK3β, contributing to HSCR development.
Area of Science:
- Molecular Biology
- Epigenetics
- Developmental Biology
Background:
- N6-methyladenosine (m6A) is the most prevalent mRNA modification in mammals, influencing diverse biological processes.
- VIRMA, a crucial methyltransferase, plays a significant role in m6A modification.
- The specific involvement of VIRMA in Hirschsprung's disease (HSCR) remains largely unexplored.
Purpose of the Study:
- To investigate the functional role of VIRMA in the pathogenesis of Hirschsprung's disease (HSCR).
- To elucidate the molecular mechanisms underlying VIRMA's function in HSCR.
- To identify potential molecular markers for HSCR diagnosis and prognosis.
Main Methods:
- Quantitative real-time PCR (RT-qPCR), Western blotting, and immunohistochemistry were employed to assess VIRMA and GSK3β expression in HSCR colon tissues.
- Immunofluorescence assays were utilized to determine the cellular localization of VIRMA and GSK3β.
- Cell proliferation and migration were evaluated using CCK8, EdU, cell migration, and wound healing assays. mRNA stability was assessed via actinomycin D assays, and m6A levels were measured colorimetrically.
Main Results:
- VIRMA expression was significantly downregulated in the narrow-segment colon tissues of HSCR patients.
- Suppression of VIRMA led to inhibited cell proliferation and migration.
- VIRMA was found to stabilize GSK3β mRNA, thereby increasing GSK3β expression, which was concurrently upregulated in HSCR tissues.
- GSK3β was identified as the mediator of VIRMA's effects on cell migration and proliferation.
Conclusions:
- VIRMA plays a protective role in HSCR by inhibiting cell migration and proliferation through the upregulation of GSK3β.
- Reduced VIRMA expression and elevated GSK3β levels are characteristic of HSCR and may serve as valuable molecular markers.
- Understanding the VIRMA-GSK3β axis offers potential therapeutic targets for HSCR.
Related Concept Videos
Abnormal Proliferation
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Cytoskeletal Coordination in Cell Migration

